Dharmesh Kant, Head of Research at Chola Securities, said Sun Pharma’s all-cash acquisition of Organon could improve return ratios and support valuations, but may...
Earlier this month, the Japanese Foreign Ministry released its 2026 Diplomatic Bluebook; an annual report on the state of the island nation’s foreign policy...